
Novan Investor Relations Material
Latest events

Q1 2023
Novan
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novan Inc
Access all reports
Novan Inc. is a biotechnology company specializing in the development of nitric oxide-based therapies for dermatological and infectious diseases. The company’s proprietary NITRICIL platform enables the controlled release of nitric oxide to target specific medical conditions. Novan’s pipeline includes treatments for skin diseases such as acne, atopic dermatitis, and warts, as well as broader applications in antiviral and antimicrobial therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NOVN
Country
🇺🇸 United States